These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability. Mazier W; Saucisse N; Simon V; Cannich A; Marsicano G; Massa F; Cota D Mol Metab; 2019 Oct; 28():151-159. PubMed ID: 31420305 [TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system regulates the moderate exercise-induced enhancement of learning and memory in mice. Wang H; Han J J Sports Med Phys Fitness; 2020 Feb; 60(2):320-328. PubMed ID: 31974335 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1. Zou S; Somvanshi RK; Kumar U Neuroscience; 2017 Jan; 340():218-231. PubMed ID: 27984180 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus. Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509 [TBL] [Abstract][Full Text] [Related]
14. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
15. Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes. Osborne KD; Lee W; Malarkey EB; Irving AJ; Parpura V ASN Neuro; 2009 Dec; 1(5):. PubMed ID: 19906012 [TBL] [Abstract][Full Text] [Related]
16. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. Hryhorowicz S; Kaczmarek-Ryś M; Andrzejewska A; Staszak K; Hryhorowicz M; Korcz A; Słomski R Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771126 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. Navarro-Romero A; Vázquez-Oliver A; Gomis-González M; Garzón-Montesinos C; Falcón-Moya R; Pastor A; Martín-García E; Pizarro N; Busquets-Garcia A; Revest JM; Piazza PV; Bosch F; Dierssen M; de la Torre R; Rodríguez-Moreno A; Maldonado R; Ozaita A Neurobiol Dis; 2019 May; 125():92-106. PubMed ID: 30685352 [TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications. Kulkarni AR; Garai S; Janero DR; Thakur GA Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808 [TBL] [Abstract][Full Text] [Related]
19. SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner. Hájková A; Techlovská Š; Dvořáková M; Chambers JN; Kumpošt J; Hubálková P; Prezeau L; Blahos J Neuropharmacology; 2016 Aug; 107():201-214. PubMed ID: 26970018 [TBL] [Abstract][Full Text] [Related]